Physiology and Pharmacology
Scope & Guideline
Catalyzing discoveries in physiology and pharmacology.
Introduction
Aims and Scopes
- Pharmacological Mechanisms and Drug Development:
The journal publishes studies on the mechanisms of action of various pharmacological agents, including their effects on cellular and physiological processes. This includes research on drug interactions, side effects, and potential therapeutic applications. - Physiological Responses to Pharmacological Interventions:
Research focusing on how different pharmacological agents affect physiological functions in various biological systems, including cardiovascular, metabolic, and neurological responses. - Molecular and Cellular Biology:
The journal emphasizes studies that explore molecular and cellular mechanisms underlying physiological processes and disease states, utilizing advanced techniques such as genomics, proteomics, and metabolomics. - Clinical Research and Therapeutics:
A significant portion of the journal's content includes clinical trials and studies that evaluate the efficacy and safety of new therapeutic interventions in humans, particularly in areas such as metabolic diseases, cancer, and neurodegenerative disorders. - Experimental Models of Disease:
The journal features research utilizing animal models to investigate disease mechanisms, progression, and potential therapeutic strategies, contributing to the translational aspect of pharmacology and physiology.
Trending and Emerging
- MicroRNA and Gene Regulation:
Research focusing on the role of microRNAs in gene regulation and their implications in various diseases has gained momentum, reflecting a growing interest in understanding post-transcriptional regulation and its therapeutic potential. - Personalized Medicine and Pharmacogenomics:
There is an increasing trend towards studies that explore personalized medicine approaches, including pharmacogenomic research that investigates how genetic variations affect individual responses to drugs. - Immunotherapy and Cancer Research:
The journal has seen a rise in papers addressing immunotherapeutic strategies for cancer treatment, highlighting innovative approaches that harness the immune system to target malignancies. - Neuropharmacology and Mental Health:
There is a growing emphasis on neuropharmacological studies, particularly those that explore the pharmacological management of mental health disorders, reflecting a heightened awareness of the importance of mental health. - Gut Microbiome and Metabolic Health:
Emerging research linking the gut microbiome to metabolic health and disease is trending, with studies focusing on how microbiota composition influences drug metabolism and overall health.
Declining or Waning
- Traditional Herbal Medicine Studies:
While herbal medicine has been a topic of interest, there has been a noticeable decrease in studies focusing solely on traditional herbal remedies, possibly due to a shift towards more evidence-based pharmacological research. - Basic Biochemistry Studies:
Research purely centered around basic biochemistry without direct application to physiology or pharmacology is less frequently published, as the journal emphasizes studies with translational or clinical relevance. - Aging and Longevity Research:
Although aging remains a critical area of research, specific studies focused on aging without a pharmacological or therapeutic angle have become less common, reflecting a trend towards more applied research. - In vitro Studies without Clinical Correlation:
There is a decreasing trend in purely in vitro studies that do not link findings to clinical implications or in vivo models, as there is a growing demand for research that can be directly translated into therapeutic applications. - Historical Perspectives on Pharmacology:
Papers that focus on historical analysis or reviews without presenting new data or insights are appearing less frequently, indicating a preference for original research contributions.
Similar Journals
CELLULAR SIGNALLING
Illuminating Pathways in Biochemistry and GeneticsCELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.
Acta Physiologica
Fostering Collaboration in Physiological SciencesActa Physiologica is a premier, peer-reviewed journal published by WILEY, dedicated to the dissemination of high-quality research across the field of physiology. With an impressive impact factor reflective of its Q1 category ranking in Physiology for 2023, this journal is a vital resource for researchers, professionals, and students alike, seeking to explore the complexities of biological systems. The journal is indexed with a commendable Scopus rank of #18 out of 193 in its category, placing it within the top 10% of its field, which underscores its influence and citation frequency within the academic community. Acta Physiologica publishes a variety of articles that address fundamental physiological concepts, innovative methodologies, and cross-disciplinary research. With its open access options, the journal ensures that cutting-edge knowledge is readily accessible, fostering an environment of collaboration and advancement in the study of physiology. Spanning from 2006 to 2024, the journal continues to be at the forefront of physiological research and education, encouraging the global sharing of knowledge through its comprehensive content.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
Championing High-Quality Research Since 1964Canadian Journal of Physiology and Pharmacology, published by Canadian Science Publishing, is a leading peer-reviewed journal dedicated to advancing knowledge in the fields of physiology and pharmacology. With an ISSN of 0008-4212 and an E-ISSN of 1205-7541, this journal has been at the forefront of biomedical research since its inception in 1964. The journal operates within a constrained access model, ensuring a selective dissemination of high-quality research, while maintaining its esteemed position in the Q3 quartile across multiple relevant categories such as Medicine, Pharmacology, and Physiology as of 2023. Researchers, professionals, and students alike will find the journal a valuable resource for emerging trends and comprehensive studies that shape contemporary science, as evidenced by its competitive Scopus rankings. The Canadian Journal of Physiology and Pharmacology is vital for fostering scholarly dialogue and innovation in the scientific community, encouraging contributions that promote a deeper understanding of physiological and pharmacological phenomena.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Unraveling the Molecular Mysteries of DiseaseBIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Innovating Therapeutic Strategies for a Healthier TomorrowThe JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS
Unlocking Insights into Stress and HealthSTRESS - THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to advancing our understanding of stress and its biological underpinnings. Established in 1996 and continuing until 2024, this journal is pivotal in the exploration of stress across multiple dimensions, including its impact on mental health, neurobiology, and endocrine systems. With an impressive categorization in Q2 and Q3 quartiles across various fields such as Behavioral Neuroscience, Psychiatry, and Physiology, STRESS ranks commendably within its discipline, positioning itself as a vital resource for researchers and professionals alike. As of 2022, the journal's open access policy enhances visibility and accessibility, fostering a broader dissemination of knowledge. The journal invites submissions from a diverse range of disciplines, aiming to bridge gaps across fields and encourage interdisciplinary collaboration. By addressing the multifaceted nature of stress, STRESS remains essential for those eager to contribute to this dynamic and critical area of research.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA
Illuminating Pathways in Biomedical Research with Insightful Articles.ACTA BIOCHIMICA ET BIOPHYSICA SINICA, an esteemed journal published by SCIENCE PRESS, is a leading platform in the fields of biochemistry, biophysics, and molecular biology. Based in the United Kingdom, this journal has consistently ranked in the Q2 category for Biochemistry, Biophysics, and Medicine (miscellaneous) in 2023, showcasing its commitment to high-quality research and innovation in life sciences. With a convergence period extending from 1996 to 2024, it features critical insights into biochemical and biophysical processes that underlie biological phenomena. Researchers and professionals seeking to stay at the forefront of discoveries will find its articles to be both informative and transformative. Although not an open-access journal, ACTA BIOCHIMICA ET BIOPHYSICA SINICA aims to advance knowledge and foster collaboration among scientists worldwide, emphasizing its role in the dynamic landscape of biomedical research.
EXPERIMENTAL AND MOLECULAR MEDICINE
Empowering researchers with open access to cutting-edge findings.EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.
Physiological Reviews
Fostering Excellence in Physiological Research and AnalysisPhysiological Reviews is a prestigious journal published by the American Physiological Society, dedicated to advancing our understanding of physiology across various domains. With an impressive impact factor that places it in Q1 quartiles for medicine, molecular biology, and physiology as of 2023, this journal is recognized as a leading source of high-quality reviews and research analyses. The journal has been a vital resource for the scientific community since its inception in 1945, providing in-depth and comprehensive insights that are crucial for both scholars and practitioners in the field. Although not an open-access publication, it remains widely accessible through institutional subscriptions, ensuring that crucial research findings are disseminated efficiently. With Scopus rankings that place it in the top percentile across multiple categories, Physiological Reviews continues to be an essential platform for the latest advancements and discoveries in physiology, making it indispensable for researchers, professionals, and students alike.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Leading the Charge in Biochemical and Cellular DiscoveriesThe International Journal of Biochemistry & Cell Biology, published by Pergamon-Elsevier Science Ltd, stands as a pivotal resource in the fields of biochemistry and cell biology. With an ISSN of 1357-2725 and an E-ISSN of 1878-5875, this prestigious journal has been a key platform for disseminating cutting-edge research since its inception in 1995. The journal currently holds an impressive Q1 ranking in Biochemistry and a Q2 ranking in Cell Biology for the year 2023, reflecting its commitment to high-quality research and its influence within the scientific community. With a significant Scopus ranking of 94/438 in Biochemistry and 96/285 in Cell Biology, the journal plays a crucial role in advancing knowledge and fostering innovative approaches in these dynamic fields. Though it is not an open-access journal, the International Journal of Biochemistry & Cell Biology remains accessible to a wide audience, making it a vital resource for researchers, professionals, and students alike, who are eager to explore and contribute to the ongoing advancements in biochemistry and cell biology.